Ovid Hosts Conference Call to Discuss Strategic Transaction Mar 3, 2021 8:30 AM EST Click here for webcast
Press Releases Year None2021202020192018201720162015 Jul 08, 2021 Ovid Therapeutics Strengthens Board & Leadership Team to Focus Efforts on Expanding Its Neurosciences Capabilities Jul 07, 2021 Ovid Therapeutics to Present at the Ladenburg Thalmann 2021 Healthcare Conference Jun 04, 2021 Ovid Therapeutics Appoints Jeff Rona as Chief Business and Financial Officer May 26, 2021 Ovid Therapeutics Appoints Dr. Joy A. Cavagnaro and Dr. Bruce A. Sullenger to its Scientific Advisory Board May 13, 2021 Ovid Therapeutics Reports First Quarter 2021 Financial Results and Provides Corporate Update Pagination Current page 1 Page 2 Page 3 Next page next › Last page last »
